Laurent Fraisse
Director/Board Member chez GENOWAY
Profil
Laurent Fraisse is currently the Director at genOway SA, the EVP-Infectious Diseases Research & Development at Evotec (France) SAS, and a Member-Supervisory Board at Nosopharm SAS.
He was previously a Member-Global Discovery Research Board at Sanofi.
He holds a doctorate degree from Institut National Polytechnique de Toulouse.
Postes actifs de Laurent Fraisse
| Sociétés | Poste | Début |
|---|---|---|
| GENOWAY | Director/Board Member | - |
Evotec (France) SAS
 Evotec (France) SAS Miscellaneous Commercial ServicesCommercial Services Part of Evotec SE, Evotec (France) SAS is a French company that engages in research and development of physical and natural sciences. The private company is based in Toulouse, France. The company was founded in 2014. Pierre Cooremans has been the CEO of the company since 2019. | Chief Tech/Sci/R&D Officer | 01/07/2018 |
Nosopharm SAS
 Nosopharm SAS Pharmaceuticals: MajorHealth Technology Nosopharm SAS operates as a biotechnology company. It develops an anti-infective drug platform that is based on the medicinal chemistry of a novel antibiotic class used to cure life-threatening multi-resistant hospital-acquired infections. The company was founded by Philippe Villain-Guillot and Maxime Gualtieri in February 2009 and is headquartered in Nimes, France. | Director/Board Member | - |
Anciens postes connus de Laurent Fraisse
| Sociétés | Poste | Fin |
|---|---|---|
| SANOFI | Chief Tech/Sci/R&D Officer | - |
Formation de Laurent Fraisse
| Institut National Polytechnique de Toulouse | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| SANOFI | Health Technology |
| GENOWAY | Health Technology |
| Entreprise privées | 2 |
|---|---|
Evotec (France) SAS
Evotec (France) SAS Miscellaneous Commercial ServicesCommercial Services Part of Evotec SE, Evotec (France) SAS is a French company that engages in research and development of physical and natural sciences. The private company is based in Toulouse, France. The company was founded in 2014. Pierre Cooremans has been the CEO of the company since 2019. | Commercial Services |
Nosopharm SAS
Nosopharm SAS Pharmaceuticals: MajorHealth Technology Nosopharm SAS operates as a biotechnology company. It develops an anti-infective drug platform that is based on the medicinal chemistry of a novel antibiotic class used to cure life-threatening multi-resistant hospital-acquired infections. The company was founded by Philippe Villain-Guillot and Maxime Gualtieri in February 2009 and is headquartered in Nimes, France. | Health Technology |
